SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Lindstrom Ingrid Jenny (Last) (First) (Middle) C/O MITESCO, INC. 1660 HWY 100 SOUTH, SUITE 432 (Street) ST. LOUIS PARK MN 55416 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Mitesco, Inc. [ MITI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Legal Officer
	3. Date of Earliest Transaction (Month/Day/Year) 10/18/2021
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series D Convertible Preferred Stock(1)	(2)(3)	10/18/2021		P		25,000		(2)	(2)	Common Stock	105,000(2)	(3)	25,000	D
Series A Warrant to purchase Common Stock(4)	$0.5(3)(4)	10/18/2021		P		25,000		04/18/2022	10/18/2026	Common Stock	52,500	(3)	52,500	D
Series B Warrant to purchase Common Stock(5)	$0.75(3)(5)	10/18/2021		P		25,000		04/18/2022	10/18/2026	Common Stock	52,500	(3)	52,500	D

Explanation of Responses:

1. The Series D Convertible Preferred Stock (the "Series D Preferred") ranks senior to all other preferred stock of the Issuer except in relation to the Issuer's Series X Cumulative Redeemable Perpetual Preferred Stock and the Series C Convertible Preferred Stock, which ranks pari passu to the Series D Preferred, with respect to the preferences as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Issuer. The Series D Preferred accrues dividends on a quarterly basis in arrears, at the rate of 6% per annum plus accrued and unpaid dividends.

2. The number of shares of common Stock of the Issuer, par value $0.01 per share (the "Common Stock") issuable upon the conversion of each share of Series D Preferred Stock is calculated by dividing the Conversion Amount (defined in the COD as the Stated Value, $1.05 per share, plus accrued and unpaid dividends) by the $0.25 conversion price (the "Conversion Price"). The shares of Series D Preferred Stock may, at any time, at the option of the holder, be converted into fully paid and non-assessable shares of Common Stock.

3. The securities were issued to Ms. Lindstrom in a private placement offering (the "Offering") pursuant to a securities purchase agreement, dated October 18, 2021, by and between the Issuer and Ms. Lindstrom, whereby the Issuer sold to Ms. Lindstrom, for a purchase price of $25,000.00, 25,000 units (the "Units"), with each Unit consisting of (a) one share of Series D Preferred Stock, (b) one warrant (the "Series A Warrants") to purchase 2.1 shares of Common Stock at a purchase price of $0.50 per whole share of Common Stock, and (c) one warrant (the "Series B Warrants") to purchase 2.1 shares of Common Stock at a purchase price of $0.75 per whole share.

4. Each Series A Warrant represents the right to purchase 2.1 shares of Common Stock at an exercise price of $0.50 per share and was issued as part of the Offering by the Issuer. The Series A Warrants are exercisable only for whole numbers of shares of Common Stock.

5. Each Series B Warrant represents the right to purchase 2.1 shares of Common Stock at an exercise price of $0.75 per share and was issued as part of the Offering by the Issuer. The Series B Warrants are exercisable only for whole numbers of shares of Common Stock.

	/s/ Ingrid Jenny Lindstrom	10/26/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.